Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20061
20072
20114
20126
20131
20141
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Boehringer Ingelheim3
Gilead Sciences3
Debiopharm International SA2
GlaxoSmithKline2
Hoffmann-La Roche2
Bausch Health Americas, Inc.1
Federico II University1
Human Genome Sciences Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic21
Hepatitis C10
Hepatitis3
Fibrosis2
Acquired Immunodeficiency Syndrome1
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1
Hepatitis, Chronic1
Hepatitis, Viral, Human1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.